Danish biotech firm Zealand Pharma proposes former Novo Nordisk senior to board
COPENHAGEN, May 1 (Reuters) - Danish biotech firm Zealand Pharma ZELA.CO said on Friday it proposed to elect Camilla Sylvest, previous head of commercial strategy and corporate affairs at Wegovy maker Novo Nordisk NOVOb.CO, to its board of directors at an extraordinary general meeting later this month. (Reporting by Louise Rasmussen, Editing by Louise Heavens) ((Louisebreusch.rasmussen@tr.com; +45 21 27 97 79;))
Recent news on Zealand Pharma A/S
See all newsZealand falls as Berenberg cuts to 'hold' on fading survodutide hopes
Europe Research Roundup: Aixtron, Lenzing, Novo Nordisk
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up